Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × Drug Screening Assays, Antitumor × Clear all

NCT00305617 2011-05-17

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Phase NA Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms